NCT01262703View on ClinicalTrials.gov

Safety Study of a Bioresorbable Coronary Stent

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2018

Conditions
Myocardial IschemiaCoronary Artery StenosisCoronary DiseaseCoronary Artery DiseaseCoronary RestenosisCardiovascular Disease
Interventions
DEVICE

ReZolve Stent

ReZolve Sirolimus-Eluting Bioresorbable Coronary Stent

Trial Locations (1)

Unknown

Instituto Dante Pazzanese de Cardiologia, São Paulo

All Listed Sponsors
lead

REVA Medical, Inc.

INDUSTRY

NCT01262703 - Safety Study of a Bioresorbable Coronary Stent | Biotech Hunter | Biotech Hunter